Li Te Ding

US Patent:

6927056, Aug 9, 2005

Filed:

Sep 6, 2001

Appl. No.:

10/363937

Inventors:

Stephen Todd - San Francisco CA, US
Angelo M. Delegeane - Milpitas CA, US
Ameena R. Gandhi - San Francisco CA, US
Danniel B. Nguyen - San Jose CA, US
April J. A. Hafalia - Daly City CA, US
Liam Kearney - San Francisco CA, US
Yan Lu - Palo Alto CA, US
Ernestine A. Lee - Castro Valley CA, US
Narinder K. Chawla - Union City CA, US
Debopriya Das - Mountain View CA, US
Chandra S. Arvizu - San Jose CA, US
Monique G. Yao - Carmel IN, US
Deborah A. Kallick - Stanford CA, US
Vicki S. Elliott - San Jose CA, US
Li Ding - Creve Coeur MO, US
Henry Yue - Sunnyvale CA, US
Roopa M. Reddy - Fremont CA, US
Dyung Aina M. Lu - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Junming Yang - San Jose CA, US
Catherine M. Tribouley - San Francisco CA, US
Neil Burford - Durham CT, US
Mariah R. Baughn - San Leandro CA, US
Preeti G. Lal - Santa Clara CA, US
Mark L. Borowsky - Redwood City CA, US
Farrah A. Khan - Des Plaines IL, US
Rajagopal Gururajan - San Jose CA, US
Y. Tom Tang - San Jose CA, US
Janice K. Au-Young - Brisbane CA, US
Bridget A. Warren - Encinitas CA, US
Roberto Hernandez - Canterbury, GB
Brendan M. Duggan - Sunnyvale CA, US

Assignee:

Incyte Corporation - Wilmington DE

International Classification:

C12N009/64
C12N001/20
C12N015/00
C12N015/63
C07H021/04

US Classification:

435226, 4352523, 43525233, 435325, 4353201, 435348, 435419, 4352541, 4352542, 536 232

Abstract:

The invention provides a human cysteine proteases and polynucleotides which encode those proteases. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists, as well as methods for diagnosing, treating, or preventing disorders associated with aberrant expression of cysteine proteases.

US Patent:

7029897, Apr 18, 2006

Filed:

Dec 4, 2001

Appl. No.:

10/433794

Inventors:

Henry Yue - Sunnyvale CA, US
Li Ding - Creve Coeur MO, US
Preeti G. Lal - Santa Clara CA, US
Jennifer A. Griffin - Fremont CA, US
Rajagopal Gururajan - San Jose CA, US
Mariah R. Baughn - Los Angeles CA, US
Craig H. Ison - San Jose CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Catherine M. Tribouley - San Francisco CA, US
Anita Swarnakar - San Francisco CA, US
Neil Burford - Durham CT, US
Olga Bandman - Mountain View CA, US
Michael Thornton - Oakland CA, US
Farrah A. Khan - Canton MI, US
Narinder K. Chawla - Union City CA, US
Danniel B. Nguyen - San Jose CA, US
Vicki S. Elliott - San Jose CA, US
Yuming Xu - Mountain View CA, US
Yan Lu - Mountain View CA, US
April J. A. Hafalia - Daly City CA, US
Monique G. Yao - Mountain View CA, US
Ameena R. Gandhi - San Francisco CA, US
Chandra S. Arvizu - San Diego CA, US
Ian J. Forsythe - Edmonton, CA

Assignee:

Incyte Corporation - Wilmington DE

International Classification:

C12N 9/16
C12N 15/00
C12N 1/20
C07K 1/00
C07H 21/04

US Classification:

435196, 4352523, 4353201, 435 6, 536 232, 530350

Abstract:

The invention provides human kinases and phosphatases (KAP) and polnucleotides which identify and encode KAP. The invention also provides expresson vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KAP.

US Patent:

7088143, Aug 8, 2006

Filed:

May 17, 2004

Appl. No.:

10/847018

Inventors:

Li Ding - Sunnyvale CA, US
Pinaki Mazumder - Ann Arbor MI, US

Assignee:

The Regents of the University of Michigan - Ann Arbor MI

International Classification:

H03K 19/096
H03K 19/00
H03K 19/20
H03K 19/094

US Classification:

326 98, 326 93, 326112, 326119, 326121

Abstract:

A number of different dynamic circuits having improved noise tolerance and a method for designing same are provided. The circuits include a power supply node and a precharge node. Keeper circuitry is connected to the nodes and has a current-voltage characteristic that exhibits a negative differential resistance property to improve noise tolerance of the circuits.

US Patent:

7112426, Sep 26, 2006

Filed:

Nov 1, 2002

Appl. No.:

10/288798

Inventors:

Olga Bandman - Mountain View CA, US
Danniel B Nguyen - San Jose CA, US
Narinder K Chawla - Union City CA, US
April J A Hafalia - Santa Clara CA, US
Monique G Yao - Carmel IN, US
Ameena R Gandhi - San Francisco CA, US
Rajagopal Gururajan - San Jose CA, US
Li Ding - Creve Coeur MO, US
Chandra S Arvizu - San Jose CA, US
Henry Yue - Sunnyvale CA, US
Mariah R Baughn - San Leandro CA, US
Catherine M Tribouley - San Francisco CA, US
Michael B Thornton - Oakland CA, US
Vicki S Elliott - San Jose CA, US
Yan Lu - Palo Alto CA, US
Craig H Ison - San Jose CA, US
Janice K Au-Young - Brisbane CA, US
Y Tom Tang - San Jose CA, US
Yalda Azimzai - Oakland CA, US
John D Burrill - Redwood City CA, US
Gregory A Marcus - San Carlos CA, US
Kurt A Zingler - San Francisco CA, US
Dyung Aina M Lu - San Jose CA, US
Preeti G Lai - Santa Clara CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Bridget A Warren - Encinitas CA, US
Liam Kearney - San Francisco CA, US
Jennifer L Policky - San Jose CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Neil Burford - Durham CT, US

Assignee:

Incyte Corporation - Wilmington DE

International Classification:

C12N 15/54
C12N 9/12

US Classification:

435194, 435325, 4353201, 4352523, 536 232

Abstract:

The invention provides human human kinases (PKIN) and polynucleotides which identify and encode PKIN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PKIN.

US Patent:

7272807, Sep 18, 2007

Filed:

Mar 2, 2005

Appl. No.:

11/071121

Inventors:

Li Ding - Sunnyvale CA, US
Peivand Fallah Tehrani - Camarillo CA, US
Alireza Kasnavi - Sunnyvale CA, US

Assignee:

Synopsys, Inc. - Mountain View CA

International Classification:

G06F 17/50

US Classification:

716 6, 716 1, 716 4

Abstract:

An equivalent waveform for a distorted waveform used in timing and signal integrity analysis in the design of an integrated circuit is automatically generated. The equivalent waveform is produced by calculating the transition quantity of a first non-distorted waveform. The transition quantity is the amount of transition of the first non-distorted waveform that is required for the cell to produce an output waveform with a predetermined end voltage. The end point of the transition period for the distorted waveform is then determined based on when the distorted waveform has accumulated the same transition quantity. The equivalent waveform can then be formed by computing a second non-distorted waveform such that the end point of the transition period for the second non-distorted waveform coincides with the end point of the transition period for the distorted waveform.

US Patent:

7608704, Oct 27, 2009

Filed:

Mar 20, 2006

Appl. No.:

11/378616

Inventors:

Henry Yue - Sunnyvale CA, US
Monique G. Yao - Mountain View CA, US
Ameena R. Gandhi - San Francisco CA, US
Mariah R. Baughn - San Leandro CA, US
Anita Swarnakar - San Francisco CA, US
Narinder Chawla - San Leandro CA, US
Madhusudan M. Sanjanwala - Los Altos CA, US
Michael Thorton - Oakland CA, US
Vicki S. Elliott - San Jose CA, US
Yan Lu - Mountain View CA, US
Kimberly J. Gietzen - San Jose CA, US
Neil Burford - Durham CT, US
Li Ding - Creve Coeur MO, US
April J. A. Hafalia - Santa Clara CA, US
Y. Tom Tang - San Jose CA, US
Olga Bandman - Mountain View CA, US
Bridget A. Warren - Encinitas CA, US
Cynthia D. Honchell - San Carlos CA, US
Dyung Aina M. Lu - San Jose CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Sally Lee - San Francisco CA, US
Yuming Xu - Mountain View CA, US
Junming Yang - San Jose CA, US
Preeti G. Lal - Santa Clara CA, US
Bao Tran - Santa Clara CA, US
Craig H. Ison - San Jose CA, US
Brendan M. Duggan - Sunnyvale CA, US
Stephanie K. Sapperstein - Redwood City CA, US

Assignee:

Incyte Corporation - Palo Alto CA

International Classification:

C07H 21/04
C12N 15/00
C12P 21/04

US Classification:

536 237, 4353201, 435325, 435 691, 530350, 536 231

Abstract:

The invention provides human secreted proteins (SECP) and polynucleotides which identify and encode SECP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of SECP.

US Patent:

7861198, Dec 28, 2010

Filed:

Sep 28, 2007

Appl. No.:

11/863252

Inventors:

Li Ding - Sunnyvale CA, US
Peivand Tehrani - Camarillo CA, US
Jindrich Zejda - Sunnyvale CA, US
Alireza Kasnavi - Sunnyvale CA, US

Assignee:

Synopsys, Inc. - Mountain View CA

International Classification:

G06F 17/50

US Classification:

716 6

Abstract:

A method to perform timing analysis for a complex logic cell with distorted input waveform and coupled load networks is presented. Timing arc based models are used in conjunction with CCB based current models of portions of the logic cell to compute the output signal of the logic cell. For example, an intermediary signal is generated using a first timing arc based model and an equivalent coupled network output signal is generated using a channel connected block (CCB) based current model.

US Patent:

8091049, Jan 3, 2012

Filed:

Jul 2, 2008

Appl. No.:

12/166630

Inventors:

Jindrich Zejda - Sunnyvale CA, US
Narender Hanchate - Sunnyvale CA, US
Rupesh Nayak - San Ramon CA, US
Li Ding - San Jose CA, US

Assignee:

Synopsys, Inc. - Mountain View CA

International Classification:

G06F 17/50

US Classification:

716100, 716106, 716107, 716108, 716134, 716136

Abstract:

One embodiment of the present invention provides systems and techniques for generating a transistor-level description of a subcircuit. A user may want to simulate a subcircuit in a circuit using a transistor-level simulator, and one or more cells in the subcircuit may need to be sensitized so that the cells are in a desired state when the subcircuit is simulated. An embodiment modifies the subcircuit by inserting analog switches in front of the cells that need to be sensitized, so that the analog switches can be used to apply a sensitization sequence to the cells during the transistor-level simulation. The embodiment can then generate a transistor-level description of the modified subcircuit. Next, the transistor-level description of the subcircuit can be stored, thereby enabling the transistor-level simulator to simulate the subcircuit.